1,064 results match your criteria: "University College London Hospitals Biomedical Research Centre.[Affiliation]"

Background And Aims: Histopathological diagnosis is the gold standard in many acquired inflammatory, infiltrative and amyloid based peripheral nerve diseases and a sensory nerve biopsy of sural or superficial peroneal nerve is favoured where a biopsy is deemed necessary. The ability to determine nerve pathology by high-resolution imaging techniques resolving anatomy and imaging characteristics might improve diagnosis and obviate the need for biopsy in some. The sural nerve is anatomically variable and occasionally adjacent vessels can be sent for analysis in error.

View Article and Find Full Text PDF

Background: In multiple sclerosis (MS), both lesion accrual and brain atrophy predict clinical outcomes. However, it is unclear whether these prognostic features are equally relevant throughout the course of MS. Among 103 participants recruited following a clinically isolated syndrome (CIS) and followed up over 30 years, we explored (1) whether white matter lesions were prognostically more relevant earlier and brain atrophy later in the disease course towards development of secondary progressive (SP) disease; (2) if so, when the balance in prognostic contribution shifts and (3) whether optimised prognostic models predicting SP disease should include different features dependent on disease duration.

View Article and Find Full Text PDF

Background: An international panel of obesity medicine experts from multiple professional organizations examined patterns of obesity care and current obesity treatment guidelines to identify areas requiring updating in response to emerging science and clinical evidence.

Aims: The panel focused on multiple medical health and societal issues influencing effective treatment of obesity and identified several unmet needs in the definition, assessment, and care of obesity.

Methods: The panel was held in Leesburg, Virginia in September 2019.

View Article and Find Full Text PDF

Early evidence that patients with (multiple) pre-existing diseases are at highest risk for severe COVID-19 has been instrumental in the pandemic to allocate critical care resources and later vaccination schemes. However, systematic studies exploring the breadth of medical diagnoses, including common, but non-fatal diseases are scarce, but may help to understand severe COVID-19 among patients at supposedly low risk. Here, we systematically harmonized >12 million primary care and hospitalisation health records from ~500,000 UK Biobank participants into 1448 collated disease terms to systematically identify diseases predisposing to severe COVID-19 (requiring hospitalisation or death) and its post-acute sequalae, Long COVID.

View Article and Find Full Text PDF

Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction.

ESC Heart Fail

December 2024

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Article Synopsis
  • The research evaluates the shift from traditional clinical trial design for heart failure (HF) to a data-driven approach, utilizing natural language processing to analyze trial eligibility criteria.
  • Phase III trials for HF were examined to identify common inclusion and exclusion criteria, finding that only about 20% of registry patients were eligible for these trials.
  • Over time, the trials have become more restrictive, with a significant decline in patient eligibility from 40% in earlier years to 19% in recent years, highlighting the need for a better design framework for future trials.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates mitral annulus disjunction (MAD) using cardiac MRI in a group of 222 patients with an average age of 49.2 years, primarily male (56.8%).
  • MAD is identified by a separation of 2 mm or more between the left ventricular myocardium and the mitral annulus, and the study analyzes late gadolinium enhancement (LGE) patterns and ventricular arrhythmias (VA).
  • Results show that although non-sustained ventricular arrhythmias were more common in patients with greater MAD extent, no strong relationship between LGE and MAD severity was found, with no observed sustained VAs during the follow-up period of approximately 4 years.
View Article and Find Full Text PDF

Investigation of the genetic aetiology of Lewy body diseases with and without dementia.

Brain Commun

May 2024

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.

Article Synopsis
  • - Up to 80% of patients with Parkinson's disease experience dementia, but the timing varies widely, and the relationship between Parkinson's disease dementia and dementia with Lewy bodies is still debated.
  • - A study analyzed genetic data from 7804 patients to investigate how genetic factors influence the development of dementia in Lewy body diseases, revealing certain risk and protective alleles.
  • - Key findings include the identification of the risk allele rs429358, which increases the odds of developing dementia, and protective alleles near specific genes that may help prevent it, highlighting the need for further research with confirmed cases.
View Article and Find Full Text PDF

Background: Early evidence that patients with (multiple) pre-existing diseases are at highest risk for severe COVID-19 has been instrumental in the pandemic to allocate critical care resources and later vaccination schemes. However, systematic studies exploring the breadth of medical diagnoses are scarce but may help to understand severe COVID-19 among patients at supposedly low risk.

Methods: We systematically harmonized >12 million primary care and hospitalisation health records from ~500,000 UK Biobank participants into 1448 collated disease terms to systematically identify diseases predisposing to severe COVID-19 (requiring hospitalisation or death) and its post-acute sequalae, Long COVID.

View Article and Find Full Text PDF

Method: 2D/3D kV imaging and CBCT data using 6 degrees of freedom (6DoF) were compared to evaluate inter and intrafraction motion.

Results: Results showed that intrafraction errors were low and interfraction levels were within institutional protocols.

Conclusion: Confidence was given to use low dose 2D/3D kV imaging to confirm daily patient set up errors, and to use pre-treatment CBCT only once weekly for additional imaging information.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the effectiveness of the Inclusion Body Myositis Functional Rating Scale (IBMFRS) in measuring physical function in patients with IBM, focusing on its validity, reliability, responsiveness, and meaningful change threshold.
  • Data were collected from a 20-month multi-center clinical trial, employing various statistical methods to test the scale’s performance, revealing strong correlations with other health outcomes and reliability in its administration formats.
  • Results indicated that IBMFRS is a dependable tool for evaluating the impact of IBM on patients, with a score drop of 2 points considered a significant decline in function.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explored the rate of sick notes (fit notes) issued for individuals recovering from COVID-19 in the years 2020, 2021, and 2022, highlighting the economic impact and health inequalities associated with long-term sickness absence.
  • - Data was collected from the OpenSAFELY-TPP database, analyzing records from over 1.3 million people diagnosed with COVID-19 and comparing their sick note rates to a matched general population.
  • - Results showed a decline in sick note rates over the years, with a peak in 2020 (4.88 per 100 person-months) and a decrease to 1.73 in 2022, suggesting that COVID-19's impact
View Article and Find Full Text PDF
Article Synopsis
  • Mutations in a specific gene are linked to Gaucher disease and significantly increase the risk for Parkinson's disease, but studying this gene is challenging due to its similar pseudogene.
  • By using long-read RNA sequencing, researchers were able to differentiate and quantify expression levels between the gene and its pseudogene, finding previously unrecognized transcripts.
  • The study revealed that many transcripts from both genes do not have the known lysosomal functions, indicating they may have other roles in the brain, which could change how we understand their impact on health and disease.
View Article and Find Full Text PDF

Background: Current guidance suggests oral antibiotics can be considered for children with acute otitis media (AOM) and ear discharge, but there is an absence of evidence regarding the relative effectiveness of antibiotic-corticosteroid eardrops.

Aim: To establish whether antibiotic-corticosteroid eardrops are non-inferior to oral antibiotics in children with AOM and ear discharge.

Design And Setting: Open randomized controlled non-inferiority trial set in Dutch primary care.

View Article and Find Full Text PDF

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

Am J Hum Genet

July 2024

Division of Psychological Medicine and Clinical Neurosciences, UK Dementia Research Institute, School of Medicine, Cardiff University, Cardiff, UK. Electronic address:

Article Synopsis
  • * A study analyzed 4,685 sporadic FTD cases and found significant genetic variants at the MAPT and APOE loci that increase the risk for the disease, indicating potential genetic overlap with other neurodegenerative diseases.
  • * The genetic risk factors appear to vary by population, with MAPT and APOE associations predominantly found in Central/Nordic and Mediterranean Europeans, suggesting a need for further research into these population-specific features for better understanding of sporadic FTD.
View Article and Find Full Text PDF

Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and Children.

Neurology

July 2024

From the Queen Square MS Centre (J.A.V., G.P., O.A.-M., Z.K., A.P., A.T.T., S.A.T., H.W., D.H.M., C.H., M.S.H., W.B., Y.H., O.C.), Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London; Department of Brain Sciences (J.A.V.), Charing Cross Hospital, Imperial College London; Department of Neurology (D.C., O.A.-M., C.H., Y.H.), Great Ormond Street Hospital for Children; The National Hospital for Neurology and Neurosurgery (T.P., Z.K., A.P., A.T.T., S.A.T., H.W., D.H.M., M.S.H., M.P.L., W.B., O.C.), UCLH NHS Trust, London, United Kingdom; Neuro-ophthalmology Expert Centre (A.P.), Amsterdam UMC, the Netherlands; Moorfields Eye Hospital NHS Foundation Trust (A.P.); Department of Radiology (K.M.), Great Ormond Street Hospital for Children; Neuroimmunology and CSF Laboratory (M.K.L.C., A.J.C., M.S.H., M.P.L.), National Hospital for Neurology and Neurosurgery; National Institute for Health and Care Research (NIHR) (M.S.H., M.P.L., W.B., O.C.), University College London Hospitals Biomedical Research Centre; and Department of Neuromuscular Diseases (M.P.L.), UCL Queen Square Institute of Neurology, University College London, United Kingdom.

Article Synopsis
  • The study evaluated the effectiveness of the 2023 myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) criteria in diagnosing inflammatory demyelinating conditions in both adults and children.
  • It analyzed data from 1,879 patients, confirming MOGAD in 16% of those tested, with follow-up averaging 3.6 years.
  • The new diagnostic criteria demonstrated high sensitivity (96.5%) and specificity (98.9%), with MOG-Ab testing showing slightly lower specificity in adults, indicating the new criteria may improve diagnosis accuracy.
View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the challenge of effectively stratifying heart failure (HF) risk despite existing therapies, proposing that portable devices that record single-lead electrocardiograms (ECGs) could improve community-based assessments.
  • An artificial intelligence (AI) algorithm was evaluated for its ability to predict HF risk from these single-lead ECGs, using data from multiple cohorts including Yale New Haven Health System, UK Biobank, and ELSA-Brasil.
  • Results indicated that individuals screened positively by the AI-ECG model had a significantly higher risk for developing HF, with increases in risk correlating with higher model probabilities, suggesting it could be a valuable tool for early identification of at-risk patients
View Article and Find Full Text PDF

Digital twins: reimagining the future of cardiovascular risk prediction and personalised care.

Hellenic J Cardiol

June 2024

Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Institute of Health Informatics, University College London, London, United Kingdom; The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK.

The rapid evolution of highly adaptable and reusable artificial intelligence models facilitates the implementation of digital twinning and has the potential to redefine cardiovascular risk prevention. Digital twinning combines vast amounts of data from diverse sources to construct virtual models of an individual. Emerging artificial intelligence models, called generalist AI, enable the processing of different types of data, including data from electronic health records, laboratory results, medical texts, imaging, genomics, or graphs.

View Article and Find Full Text PDF

Genome-wide determinants of mortality and motor progression in Parkinson's disease.

NPJ Parkinsons Dis

June 2024

Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.

Article Synopsis
  • * A study involving 6,766 PD patients over several years examined how genetic factors influence motor progression and mortality, revealing the APOE ε4 allele as significantly impacting mortality rates.
  • * Four new genetic loci were identified, linked to motor progression, suggesting potential targets for future treatment strategies in PD, although further investigation is necessary to understand their biological implications.
View Article and Find Full Text PDF

Introduction: Severe osteogenesis imperfecta (OI) is a debilitating disease with no cure or sufficiently effective treatment. Mesenchymal stem cells (MSCs) have good safety profile, show promising effects and can form bone. The Boost Brittle Bones Before Birth (BOOSTB4) trial evaluates administration of allogeneic expanded human first trimester fetal liver MSCs (BOOST cells) for OI type 3 or severe type 4.

View Article and Find Full Text PDF

An unmet need exists for patients with relapsed/refractory (R/R) follicular lymphoma (FL) and high-risk disease features, such as progression of disease within 24 months (POD24) from first-line immunochemotherapy or disease refractory to both CD20-targeting agent and alkylator (double refractory), due to no established standard of care and poor outcomes. Chimeric antigen receptor (CAR) T cell therapy is an option in R/R FL after two or more lines of prior systemic therapy, but there is no consensus on its optimal timing in the disease course of FL, and there are no data in second-line (2L) treatment of patients with high-risk features. Lisocabtagene maraleucel (liso-cel) is an autologous, CD19-directed, 4-1BB CAR T cell product.

View Article and Find Full Text PDF

Objectives: To investigate the frequency and factors associated with disease flare following vaccination against SARS-CoV-2 in people with inflammatory/autoimmune rheumatic and musculoskeletal diseases (I-RMDs).

Methods: Data from the European Alliance of Associations for Rheumatology Coronavirus Vaccine physician-reported registry were used. Factors associated with flare in patients with I-RMDs were investigated using multivariable logistic regression adjusted for demographic and clinical factors.

View Article and Find Full Text PDF

Brain metastases (BMs) arising from ovarian cancer remain rare. Spinal cord metastases are even rarer, accounting for just 0.4% of total metastatic spinal cord compressions.

View Article and Find Full Text PDF

Regional Distribution of Extracellular Volume Quantified by Cardiac CT in Aortic Stenosis: Insights Into Disease Mechanisms and Impact on Outcomes.

Circ Cardiovasc Imaging

May 2024

Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (K.P.P., P.R.S., B.S., A.S., J.J.L.Y.-S., E.C., M.M., L.J.M., J.C.M., F.P., T.A.T.).

Background: Extracellular volume fraction (ECV) is a marker for myocardial fibrosis and infiltration, can be quantified using cardiac computed tomography (ECV), and has prognostic utility in several diseases. This study aims to map out regional differences in ECV to obtain greater insights into the pathophysiological mechanisms of ECV expansion and its clinical implications.

Methods: Three prospective cohorts were included: patients with aortic stenosis (AS) and coexisting AS and transthyretin cardiac amyloidosis were referred for a transcatheter aortic valve replacement and had ECG-gated CT angiography and Technetium-99m-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy to differentiate between the 2 cohorts.

View Article and Find Full Text PDF

High altitude residents have a lower incidence of type 2 diabetes mellitus (T2DM). Therefore, we examined the effect of repeated overnight normobaric hypoxic exposure on glycaemic control, appetite, gut microbiota and inflammation in adults with T2DM. Thirteen adults with T2DM [glycated haemoglobin (HbA1): 61.

View Article and Find Full Text PDF